INS and metabolic disease: The inversely association of glutamine with metabolic disorders might be due to pancreatic β-cell insulin secretion, increased insulin sensitivity of adipose tissue, transcription of insulin-dependent enzymes, enhanced release of glucagon-like peptide 1, and externalization of glucose transporter type 4 (27–29).